ARID1A Alterations Function as a Biomarker for Longer Progression-Free Survival After Anti-Pd-1/Pd-L1 Immunotherapy
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1136/jitc-2019-000438
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2020
Authors
Publisher
BMJ